welcome
Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Business

Business & Economics

Jim Cramer Warns on Pfizer (PFE): “That 7.7% Yield Is Not a Sign of Strength – It’s a Sign of Weakness”

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
Summary
Nutrition label

64% Informative

Pfizer Inc. ( NYSE : PFE ) is engaged in researching, developing, producing, and distributing biopharmaceutical drugs.

The company is involved in treatments for heart disease, infectious diseases, cancer, immune disorders, and vaccines.

Overall, PFE ranks 1st on our list of stocks that Jim Cramer discussed on April 17 .

There is an AI stock that went up since the beginning of 2025 , while popular AI stocks lost around 25% . If you are looking for an AI stock that is more promising than PFE but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. Disclosure: None. This article is originally published at Insider Monkey ..

VR Score

56

Informative language

49

Neutral language

19

Article tone

informal

Language

English

Language complexity

36

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links